Trial · NCT04684238
Results by group30
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 30
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Time of Adequately Maintained Sedation Depth up to 48 Hours (± 6 Hours) | Drug: Midazolam | 62.37 | 95% Confidence Interval 44.70 to 80.04 | Percentage of time | |
| Percentage of Time of Adequately Maintained Sedation Depth up to 48 Hours (± 6 Hours) | Drug: Isoflurane | 68.94 | 95% Confidence Interval 52.83 to 85.05 | Percentage of time | |
| Percentage of Time of Adequately Maintained Sedation Depth up to 48 Hours (± 6 Hours) | Drug: Midazolam | 65.57 | 95% Confidence Interval 44.03 to 87.11 | Percentage of time | |
| Percentage of Time of Adequately Maintained Sedation Depth up to 48 Hours (± 6 Hours) | Drug: Isoflurane | 70.91 | 95% Confidence Interval 50.75 to 91.07 | Percentage of time | |
| Compare the Use of Opioids | Drug: Midazolam | 4.6 | 95% Confidence Interval 3.5 to 5.6 | μg/kg/h | |
| Compare the Use of Opioids | Drug: Isoflurane | 2.1 | 95% Confidence Interval 1.3 to 2.9 | μg/kg/h | |
| Compare the Use of Opioids | Drug: Midazolam | 0.58 | 95% Confidence Interval -0.16 to 1.32 | μg/kg/h | |
| Compare the Use of Opioids | Drug: Isoflurane | -0.19 | 95% Confidence Interval -0.74 to 0.35 | μg/kg/h | |
| Compare Time From End of Study Drug Administration to Extubation | Drug: Midazolam | 1.09 | Inter-Quartile Range 0.49 to 5.50 | hour | |
| Compare Time From End of Study Drug Administration to Extubation | Drug: Isoflurane | 0.75 | Inter-Quartile Range 0.25 to 1.5 | hour | |
| Compare the Proportion of Time With Spontaneous Breathing | Drug: Midazolam | 0.44 | 95% Confidence Interval 0.28 to 0.59 | proportion of time | |
| Compare the Proportion of Time With Spontaneous Breathing | Drug: Isoflurane | 0.48 | 95% Confidence Interval 0.36 to 0.60 | proportion of time | |
| Evaluate Haemodynamic Effect as Indicated by Need for Additional Inotropic/Vasopressor Agent | Drug: Midazolam | ≤24 hours | 5.4 | Standard Deviation 19.3 | Change from baseline in VIS |
| Evaluate Haemodynamic Effect as Indicated by Need for Additional Inotropic/Vasopressor Agent | Drug: Isoflurane | ≤24 hours | 3.4 | Standard Deviation 19.9 | Change from baseline in VIS |
| Evaluate Haemodynamic Effect as Indicated by Need for Additional Inotropic/Vasopressor Agent | Drug: Midazolam | >24 hours | 1.9 | Standard Deviation 9.7 | Change from baseline in VIS |
| Evaluate Haemodynamic Effect as Indicated by Need for Additional Inotropic/Vasopressor Agent | Drug: Isoflurane | >24 hours | 8.8 | Standard Deviation 44.4 | Change from baseline in VIS |
| Evaluate the Number of Patients With Withdrawal Symptom | Drug: Midazolam | 2 | Participants | ||
| Evaluate the Number of Patients With Withdrawal Symptom | Drug: Isoflurane | 3 | Participants | ||
| Evaluate the Frequency of Delirium | Drug: Midazolam | 5 | Participants | ||
| Evaluate the Frequency of Delirium | Drug: Isoflurane | 12 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04684238/results